欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称Filsuvez
适用类别Human
治疗领域Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa, Junctional
通用名/非专利名称birch bark extract
活性成分dry extract from birch bark (DER 5-10 : 1), extraction solvent n-heptane 95% (w/w)
产品号EMEA/H/C/005035
患者安全信息no
授权状态Authorised
ATC编码D03AX13
是否额外监管no
是否仿制药no
是否生物类似药no
是否附条件批准no
是否特殊情形no
是否加速审评no
是否罕用药yes
批准上市日期2022/06/21
上市许可持有人/公司名称Amryt Pharmaceuticals DAC
人用药物治疗分组Preparations for treatment of wounds and ulcers
审评意见发布日期2022/04/22
决定日期2023/10/17
修订号2
适应症Treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in patients 6 months and older.
首次发布日期2022/04/13
修订日期2023/10/17
产品信息https://www.ema.europa.eu/en/documents/product-information/filsuvez-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/human/EPAR/filsuvez
©2006-2024 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase